₹0.40
(Market cap
₹7 Cr
Revenue (TTM)
₹14 Cr
P/E Ratio
--
P/B Ratio
0.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-4 Cr
-
ROE
-22.7 %
-
ROCE
-28.4 %
-
Industry P/E
45.19
-
EV/EBITDA
-2.2
-
Debt to Equity
0
-
Book Value
₹20.5
-
EPS
₹-4.3
-
Face value
10
-
Shares outstanding
10,100,000
10 Years Aggregate
CFO
₹-11.74 Cr
EBITDA
₹-5.37 Cr
Net Profit
₹3.57 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Decipher Labs
| -32.1 | -1.4 | 17.9 | -35.4 | -26.6 | -29.6 | 6.8 |
|
BSE Healthcare*
| 11.9 | 2.8 | 17.6 | 13.0 | 25.0 | 14.3 | 12.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Decipher Labs
| -37.0 | -15.7 | -44.8 | -77.4 | 287.8 | 14.6 | 38.4 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Decipher Labs
|
7.1 | 7.2 | 14.1 | -4.3 | -27.8 | -21.6 | -- | 0.3 |
| 3,288.3 | 26,802.2 | 1,339.4 | 356.4 | 33.2 | 23.2 | 75.2 | 16.2 | |
| 458.2 | 17,523.5 | 2,268.6 | 150.1 | 10.6 | 5.4 | 97.8 | 4.5 | |
| 788.5 | 19,507.8 | 5,365.6 | 595.0 | 16.6 | 13.3 | 32.8 | 3.8 | |
| 910.8 | 15,993.6 | 4,078.3 | 1,371.9 | 30.2 | 15.9 | 11.3 | 1.7 | |
| 1,556.6 | 17,968.4 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.1 | |
| 173.7 | 22,459.8 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.8 | |
| 1,406.4 | 22,947.7 | 1,284.3 | 134.4 | -- | 30.7 | 93 | 17.8 | |
| 440.3 | 17,604.0 | 3,738.7 | 316.7 | 12.5 | 7.5 | 55.6 | 3.6 | |
| 2,043.0 | 32,672.3 | 3,373.0 | 199.0 | 12.6 | 5.9 | 153.4 | 6.6 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Decipher Labs
Combat Drugs Limited manufactures and markets pharmaceutical formulations in India. The company offers its products in various forms, such as tablets, capsules, liquid orals, and ointments. The company was founded in 1986 and is based in Hyderabad,... India. Read more
-
Incorporated
1986
-
Chairman
--
-
Managing Director
--
-
Group
MNC
-
Headquarters
Hyderabad, Telangana
-
Website
Looking for more details about Decipher Labs Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
FAQs for Decipher Labs
What is the current share price of Decipher Labs Ltd Today?
The share price of Decipher Labs Ltd is ₹7.10 (BSE) as of 23-Jun-2026 IST. Decipher Labs Ltd has given a return of -26.61% in the last 3 years.
What is the current PB & PE ratio of Decipher Labs Ltd?
Since, TTM earnings of Decipher Labs Ltd is negative, P/E ratio is not available.
The P/B ratio of Decipher Labs Ltd is 0.35 times as on 23-Jun-2026, a 92 discount to its peers’ median range of 4.43 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.46
|
|
2024
|
0.00
|
0.68
|
|
2023
|
0.00
|
0.62
|
|
2022
|
4.70
|
2.21
|
|
2021
|
24.09
|
2.47
|
What is the 52 Week High and Low of Decipher Labs Ltd?
The 52-week high and low of Decipher Labs Ltd are Rs 11.95 and Rs 5.00 as of 24-Jun-2026.
What is the market cap of Decipher Labs Ltd?
Decipher Labs Ltd has a market capitalisation of ₹ 7 Cr as on 23-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Decipher Labs Ltd?
Before investing in Decipher Labs Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.